Literature DB >> 21711258

What initiates a migraine attack? Conclusions from four longitudinal studies of quantitative EEG and steady-state visual-evoked potentials in migraineurs.

M Bjørk1, L J Stovner, K Hagen, T Sand.   

Abstract

OBJECTIVES: Quantitative electroencephalograpic (QEEG) frequency spectra and steady-state visual-evoked potentials (SSVEP) are indicators of corticothalamic excitability (e.g., arousal). Increased interictal excitability is suggested to be an important element in the migraine pathophysiology. In this paper, we summarize our results from four studies of QEEG and SSVEP recordings in migraineurs interictally and in the days before an attack with the intention to shed light on attack-initiating mechanisms.
MATERIAL AND METHODS: Thirty-two healthy controls, 33 migraineurs without and eight with aura each had three EEGs with photic stimulation on different days. Using the patient headache diaries, we classified the recordings as interictal, preictal, ictal, or post-ictal retrospectively. Interictal recordings were compared pairwise with attack-related EEGs from the same patient as well as with control EEGs. We also correlated clinical variables with the QEEG and SSVEP data.
RESULTS: Between attacks, we found increased relative theta activity and attenuated medium-frequency photic responses in migraineurs without aura compared with those in controls. Within 36 h before the attack, slow and asymmetric EEG activity developed. Increased trigger sensitivity and photophobia correlated with higher theta power and depressed photic responses. Attack duration, migraine history duration, and pain intensity were associated with EEG slowing.
CONCLUSIONS: A general tendency toward EEG slowing and depression of photic responses characterized the migraine group. This pattern was also related to increased severity of symptoms. A change in cortical activity occurred within 36 h before attacks. Our results indicate that thalamocortical hypoexcitability is associated with attack initiation and sensory hypersensitivity in migraine.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Year:  2011        PMID: 21711258     DOI: 10.1111/j.1600-0404.2011.01545.x

Source DB:  PubMed          Journal:  Acta Neurol Scand Suppl        ISSN: 0065-1427


  6 in total

1.  RNA-Seq investigations of human post-mortem trigeminal ganglia.

Authors:  Danielle M LaPaglia; Matthew R Sapio; Peter D Burbelo; Jean Thierry-Mieg; Danielle Thierry-Mieg; Stephen J Raithel; Christopher E Ramsden; Michael J Iadarola; Andrew J Mannes
Journal:  Cephalalgia       Date:  2017-07-12       Impact factor: 6.292

2.  Effectiveness of Transcranial Direct Current Stimulation and Monoclonal Antibodies Acting on the CGRP as a Combined Treatment for Migraine (TACTIC): Protocol for a Randomized, Double-Blind, Sham-Controlled Trial.

Authors:  Raffaele Ornello; Chiara Rosignoli; Valeria Caponnetto; Francesca Pistoia; Michele Ferrara; Aurora D'Atri; Simona Sacco
Journal:  Front Neurol       Date:  2022-05-10       Impact factor: 4.086

3.  Current understanding of cortical structure and function in migraine.

Authors:  Else A Tolner; Shih-Pin Chen; Katharina Eikermann-Haerter
Journal:  Cephalalgia       Date:  2019-03-28       Impact factor: 6.292

4.  Abnormalities in cortical pattern of coherence in migraine detected using ultra high-density EEG.

Authors:  Alireza Chamanzar; Sarah M Haigh; Pulkit Grover; Marlene Behrmann
Journal:  Brain Commun       Date:  2021-04-02

5.  Resilience in migraine brains: decrease of coherence after photic stimulation.

Authors:  Mayara Mendonça-de-Souza; Ubirakitan M Monteiro; Amana S Bezerra; Ana P Silva-de-Oliveira; Belvânia R Ventura-da-Silva; Marcelo S Barbosa; Josiane A de Souza; Elisângela C Criado; Maria C M Ferrarezi; Giselly de A Alencar; Otávio G Lins; Maria das G W S Coriolano; Belmira L S A Costa; Marcelo C A Rodrigues
Journal:  Front Hum Neurosci       Date:  2012-07-24       Impact factor: 3.169

6.  Sleep quality, arousal and pain thresholds in migraineurs: a blinded controlled polysomnographic study.

Authors:  Morten Engstrøm; Knut Hagen; Marte Helene Bjørk; Lars Jacob Stovner; Gøril Bruvik Gravdahl; Marit Stjern; Trond Sand
Journal:  J Headache Pain       Date:  2013-02-14       Impact factor: 7.277

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.